Zhenyu Zhu

7.9k total citations
263 papers, 6.3k citations indexed

About

Zhenyu Zhu is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Zhenyu Zhu has authored 263 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Molecular Biology, 34 papers in Complementary and alternative medicine and 31 papers in Pharmacology. Recurrent topics in Zhenyu Zhu's work include Traditional Chinese Medicine Analysis (29 papers), Metabolomics and Mass Spectrometry Studies (22 papers) and Analytical Chemistry and Chromatography (21 papers). Zhenyu Zhu is often cited by papers focused on Traditional Chinese Medicine Analysis (29 papers), Metabolomics and Mass Spectrometry Studies (22 papers) and Analytical Chemistry and Chromatography (21 papers). Zhenyu Zhu collaborates with scholars based in China, United States and Australia. Zhenyu Zhu's co-authors include Yifeng Chai, Xiaofei Chen, Hai Zhang, Guangguo Tan, Yan Cao, Ziyang Lou, Xin Dong, Yuanying Jiang, Zhanying Hong and Wuhong Li and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Zhenyu Zhu

253 papers receiving 6.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenyu Zhu China 42 3.3k 805 743 515 504 263 6.3k
Xiaohui Fan China 47 3.8k 1.1× 1.1k 1.4× 902 1.2× 638 1.2× 407 0.8× 319 7.9k
Chun Guang Li Australia 51 2.9k 0.9× 1000 1.2× 1.1k 1.4× 734 1.4× 789 1.6× 308 9.3k
Ying Xie China 47 3.4k 1.0× 701 0.9× 1.1k 1.5× 500 1.0× 666 1.3× 288 7.7k
Yong Liu China 44 3.1k 0.9× 392 0.5× 955 1.3× 638 1.2× 752 1.5× 341 7.1k
Xin Wang China 45 2.8k 0.8× 421 0.5× 682 0.9× 248 0.5× 440 0.9× 402 8.0k
Yanan Wang China 44 3.8k 1.1× 317 0.4× 448 0.6× 787 1.5× 686 1.4× 489 8.4k
Olivier Cloarec United Kingdom 33 5.6k 1.7× 442 0.5× 411 0.6× 390 0.8× 194 0.4× 50 7.6k
Gang Bai China 33 2.0k 0.6× 583 0.7× 632 0.9× 490 1.0× 385 0.8× 282 4.5k
Aihua Zhao China 48 4.3k 1.3× 551 0.7× 518 0.7× 304 0.6× 224 0.4× 132 6.9k

Countries citing papers authored by Zhenyu Zhu

Since Specialization
Citations

This map shows the geographic impact of Zhenyu Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenyu Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenyu Zhu more than expected).

Fields of papers citing papers by Zhenyu Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenyu Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenyu Zhu. The network helps show where Zhenyu Zhu may publish in the future.

Co-authorship network of co-authors of Zhenyu Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenyu Zhu. A scholar is included among the top collaborators of Zhenyu Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenyu Zhu. Zhenyu Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Yao, Liqiang Wu, Suying Lü, et al.. (2025). 336P: Durvalumab (D) as consolidation therapy for limited-stage small-cell lung cancer (LS-SCLC): ADRIATIC China subgroup analysis. Journal of Thoracic Oncology. 20(3). S203–S204.
2.
Zhu, Zhenyu, et al.. (2025). Mechanism of chondrocyte injury induced by Benzophenone-3 through modulation of the IL-6/JAK2/STAT3 pathway. Environmental Pollution. 372. 126064–126064. 3 indexed citations
3.
Zhu, Zhenyu, et al.. (2025). Carbon nanotube-mediated Ni3(PO4)2/NiCo2O4 hybrids for advanced energy storage in asymmetric supercapacitors. Solid State Sciences. 160. 107834–107834. 3 indexed citations
4.
Zhu, Zhenyu, Hao Liu, Qingchun Liang, et al.. (2025). Loss of ADAMTS5 promotes vascular calcification via versican/integrin β1/FAK signal. Atherosclerosis. 404. 119190–119190. 3 indexed citations
5.
6.
Zhu, Zhenyu, et al.. (2025). Benzophenone-3 drives osteoarthritis pathogenesis by regulating chondrocyte senescence. Chemico-Biological Interactions. 421. 111757–111757.
7.
8.
9.
Xu, Hao, Duo‐Sheng Wang, Zhenyu Zhu, Arghya Deb, & X. Peter Zhang. (2023). New mode of asymmetric induction for enantioselective radical N-heterobicyclization via kinetically stable chiral radical center. Chem. 10(1). 283–298. 22 indexed citations
10.
11.
Zhu, Zhenyu, Yanli Zhang, Hongbin Wang, et al.. (2022). A Sensitive Electrochemical Assay for T4 Polynucleotide Kinase Activity Based on Fe 3 O 4 @TiO 2 And Gold Nanoparticles Hybrid Probe Modified Magnetic Electrode. Journal of The Electrochemical Society. 169(2). 27504–27504. 29 indexed citations
12.
13.
Tang, Guiqian, Dan Yao, Yuting Liu, et al.. (2022). The urgent need to control volatile organic compound pollution over the Qinghai-Tibet Plateau. iScience. 25(12). 105688–105688. 13 indexed citations
14.
Yu, Simiao, Jingxiao Wang, Haocheng Zheng, et al.. (2022). Pathogenesis from Inflammation to Cancer in NASH-Derived HCC. SHILAP Revista de lepidopterología. Volume 9. 855–867. 11 indexed citations
15.
Song, Zhiqiang, Gusheng Tang, Chunlin Zhuang, et al.. (2022). Metabolomic profiling of cerebrospinal fluid reveals an early diagnostic model for central nervous system involvement in acute lymphoblastic leukaemia. British Journal of Haematology. 198(6). 994–1010. 6 indexed citations
16.
Yan, Weiwei, Zhenyu Zhu, Fei Pan, Ang Huang, & Guanghai Dai. (2018). Overexpression of c-kit(CD117), relevant with microvessel density, is an independent survival prognostic factor for patients with HBV-related hepatocellular carcinoma. OncoTargets and Therapy. Volume 11. 1285–1292. 12 indexed citations
17.
18.
Chen, Si, Hailong Jiang, Yan Cao, et al.. (2016). Drug target identification using network analysis: Taking active components in Sini decoction as an example. Scientific Reports. 6(1). 24245–24245. 59 indexed citations
19.
Zhang, Yi, Zhenyu Zhu, Xin Liu, et al.. (2014). RLIP76 Blockade by siRNA Inhibits Proliferation, Enhances Apoptosis, and Suppresses Invasion in HT29 Colon Cancer Cells. Cell Biochemistry and Biophysics. 71(2). 579–585. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaohui Fan Breakdown of academic impact, for papers by Chun Guang Li Breakdown of academic impact, for papers by Ying Xie Breakdown of academic impact, for papers by Yong Liu Breakdown of academic impact, for papers by Xin Wang Breakdown of academic impact, for papers by Yanan Wang Breakdown of academic impact, for papers by Olivier Cloarec Breakdown of academic impact, for papers by Gang Bai Breakdown of academic impact, for papers by Aihua Zhao
Rankless by CCL
2026